Structure and design of Langya virus glycoprotein antigens.
Zhaoqian WangMatthew McCallumLianying YanCecily A GibsonWilliam SharkeyYoung-Jun ParkHa V DangMoushimi AmayaAshley PersonChristopher C BroderDavid VeeslerPublished in: Proceedings of the National Academy of Sciences of the United States of America (2024)
Langya virus (LayV) is a recently discovered henipavirus (HNV), isolated from febrile patients in China. HNV entry into host cells is mediated by the attachment (G) and fusion (F) glycoproteins which are the main targets of neutralizing antibodies. We show here that the LayV F and G glycoproteins promote membrane fusion with human, mouse, and hamster target cells using a different, yet unknown, receptor than Nipah virus (NiV) and Hendra virus (HeV) and that NiV- and HeV-elicited monoclonal and polyclonal antibodies do not cross-react with LayV F and G. We determined cryoelectron microscopy structures of LayV F, in the prefusion and postfusion states, and of LayV G, revealing their conformational landscape and distinct antigenicity relative to NiV and HeV. We computationally designed stabilized LayV G constructs and demonstrate the generalizability of an HNV F prefusion-stabilization strategy. Our data will support the development of vaccines and therapeutics against LayV and closely related HNVs.
Keyphrases
- induced apoptosis
- cell cycle arrest
- end stage renal disease
- high resolution
- endothelial cells
- newly diagnosed
- ejection fraction
- chronic kidney disease
- cell death
- prognostic factors
- molecular dynamics
- endoplasmic reticulum stress
- peritoneal dialysis
- signaling pathway
- disease virus
- small molecule
- oxidative stress
- electronic health record
- molecular dynamics simulations
- high speed
- multiple myeloma
- dengue virus
- cell proliferation
- induced pluripotent stem cells
- pi k akt
- aedes aegypti
- label free